Radiotherapy in Hodgkin’s Lymphoma Treatment  - RAD07

Radiotherapy in Hodgkin’s Lymphoma Treatment

by Olive Peart, MS, RT(R)(M)
RAD07
(4.5 / 359 ratings )

This course is credentialed for:
Radiologic Technology (1.00 CE Credit)

ONLINE
Price: $10.00
CE-PRO Price: $5.00

Summary:

Radiotherapy is one of the primary interventions used to limit the progress of Hodgkin’s lymphoma (HL). Traditionally, chemotherapy with or without radiotherapy has been used to improve survival in patients. The decision to include radiotherapy in the treatment protocol for HL usually depends on the severity of the cancer at the time of diagnosis. Recently, studies following HL survivors for a longer duration after remission have found an increased occurrence of secondary malignant neoplasms and cardiovascular diseases. Such adverse effects lower the quality of life in surviving patients. Radiotherapeutic intervention in patients with HL should be implemented only after careful examination of patient parameters that necessitate this treatment strategy. Knowledge of risks and benefits of this intervention is helpful for recommending effective treatment plans.

Objectives:

This course provides information necessary for identifying patients with Hodgkin’s lymphoma who are eligible for radiotherapy, as well as identifying the advantages and potential risks of using radiotherapy to treat Hodgkin’s lymphoma. After completing this course, you should be able to:
  • Describe the evidence supporting the use of radiotherapy in treating Hodgkin’s lymphoma.
  • Discuss the adverse effects associated with radiotherapy.
  • Identify patients in whom radiotherapy will improve survival.
 

 
Approval Information
 
This course is intended for imaging and radiation therapists.
 
This activity is approved for Category A continuing education credit by the American Society of Radiologic Technologists (ASRT) for 08/14/2014 to 09/01/2017, and 4/16/2020 to 5/1/2021.
 
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium.

Course Originally Released on: 9/16/2013
Date of Most Recent Review: 3/31/2020
Course Termination/Update Date: 4/30/2023

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

Sort By
Amy S - Marion , IA  ·  May 13, 2020
Great topic and article.
Was this review helpful?  0
 
Colbi M - Crandall, GA  ·  May 03, 2020
very informative and gives hope of developing cancer treatments
Was this review helpful?  0
 
Leslie H - Deer Park, TX  ·  Apr 24, 2020
very informative and useful
Was this review helpful?  0
 
Tuan L - HOUSTON, TX  ·  Sep 18, 2018
this was easy to understand,great stuff
Was this review helpful?  0
 
Katrina J - Grimesland, NC  ·  Aug 19, 2018
I have nothing to say
Was this review helpful?  0
 
  Page: of 27  
ONLINE
Price: $10.00
CE-PRO Price: $5.00